Clinical Trial Update: A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to evaluate the abuse potential of single oral doses of dimebon (latrepirdine) in healthy recreational polydrug users; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease, Huntington's Disease | Phase 1 | Status: COMPLETED | Results posted: 2013-04-02